Briacell Therapeutics Corp Stock Probability of Future Stock Price Finishing Under 0.86
| BCTX Stock | USD 0.66 0.44 40.00% |
Briacell |
Briacell Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Briacell Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Briacell Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Briacell Therapeutics is way too risky over 90 days horizon | |
| Briacell Therapeutics has some characteristics of a very speculative penny stock | |
| Briacell Therapeutics appears to be risky and price may revert if volatility continues | |
| Briacell Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Briacell Therapeutics Corp currently holds about 41.04 M in cash with (24.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Briacell Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders |
Briacell Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Briacell Stock often depends not only on the future outlook of the current and potential Briacell Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Briacell Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.5 M | |
| Cash And Short Term Investments | 862.1 K |
Briacell Therapeutics Technical Analysis
Briacell Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Briacell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Briacell Therapeutics Corp. In general, you should focus on analyzing Briacell Stock price patterns and their correlations with different microeconomic environments and drivers.
Briacell Therapeutics Predictive Forecast Models
Briacell Therapeutics' time-series forecasting models is one of many Briacell Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Briacell Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Briacell Therapeutics
Checking the ongoing alerts about Briacell Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Briacell Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Briacell Therapeutics is way too risky over 90 days horizon | |
| Briacell Therapeutics has some characteristics of a very speculative penny stock | |
| Briacell Therapeutics appears to be risky and price may revert if volatility continues | |
| Briacell Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Briacell Therapeutics Corp currently holds about 41.04 M in cash with (24.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Briacell Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders |
Additional Tools for Briacell Stock Analysis
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.